LONDON (MarketWatch) -- GlaxoSmithKline, Europe’s largest drug maker, on Wednesday posted a drop in third-quarter profit and sales and said it will cut jobs to improve performance in a tougher operating environment.
LONDON (MarketWatch) -- GlaxoSmithKline, Europe’s largest drug maker, on Wednesday posted a drop in third-quarter profit and sales and said it will cut jobs to improve performance in a tougher operating environment.
